Evidence map›Paper›PMID 41731093›Full record

ArticleEuropean radiology2026

Large language model and Gd-EOB-DTPA-enhanced MRI-based risk stratification system for postoperative hepatocellular carcinoma: a multicenter study.

Can Yu, Qi Zhang, Jia-Xuan Ding, Wanhu Li, Shuai Han, Shan Cong, Xinxin Wang, Yang Zhou

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Can YuDepartment of Radiology, Harbin Medical University Cancer Hospital, Harbin, China.
Qi ZhangDepartment of Electronic Information, Harbin Engineering University Qingdao Innovation and Development Base, Qingdao, China.
Jia-Xuan DingDepartment of Radiology, Harbin Medical University Cancer Hospital, Harbin, China.
Wanhu LiDepartment of Radiology, Shandong Cancer Hospital and Institute, Jinan, China.
Shuai HanDepartment of Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
Shan CongGenome Institute of Singapore, Agency for Science, Technology and Research, Singapore, Singapore. shan.cong@hrbeu.edu.cn.
Xinxin WangDepartment of Radiology, Harbin Medical University Cancer Hospital, Harbin, China. wangxinxin@hrbmu.edu.cn.
Yang ZhouDepartment of Radiology, Harbin Medical University Cancer Hospital, Harbin, China. zhouyang094@126.com.ORCID http://orcid.org/0000-0001-5296-220X

Funding

Harbin Medical University Cancer Hospital Climbing Program PDYS202410Health Commission of Heilongjiang Province No.20230909010304Heilongjiang Provincial Basic Research Funds for Higher Education Institutions Research Project No. 2023-KYYWF-0217the National Natural Science Foundation of China U22A200260
6 · The paper itself

Abstract

objectiveTo develop and validate a Fully Automated Stratification System (FASS) integrating serum biomarkers, automated radiomic features, and large language model (LLM)-derived semantic features for prognostic prediction in patients with solitary hepatocellular carcinoma (HCC) after hepatic resection. MATERIALS AND

methodsA total of 448 patients with solitary HCC from three centers were retrospectively enrolled. Automated tumor segmentation was performed using a modified MedNeXt-loss framework, and radiomic features were extracted from Gadolinium ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced MRI. Five LLMs were compared for feature-level accuracy and completeness, and the best-performing model was incorporated into the FASS. Prognostic models based on serum, radiomic, and LLM-semantic features were integrated and evaluated using concordance index, time-dependent ROC, and decision curve analyses. Biological relevance was explored through RNA sequencing and pathway enrichment analyses.

resultsThe MedNeXt-loss framework achieved robust segmentation (Dice = 0.77). ChatGPT-4o demonstrated the best balance between predictive accuracy and completeness and was used for subsequent modeling. In multivariate analysis, AFP, AST, and the ChatGPT-4o-derived irregular margin were independent predictors of overall survival. The integrated FASS achieved high prognostic performance (C-index 0.78 and 0.76 in test and external validation cohorts) and effectively stratified patients into distinct risk groups (log-rank p < 0.05). Transcriptomic analyses revealed inflammatory and cytokine signaling activation in the high-risk group.

conclusionFASS enables fully automated, interpretable, and biologically informed prognostic assessment in solitary HCC, supporting precision decision-making in hepatobiliary oncology. KEY POINTS: QuestionCan large language models improve preoperative hepatocellular carcinoma risk stratification by integrating advanced image interpretation and semantic analysis? FindingsThe system enabled fully automated analysis, identified AFP, AST and LLM-derived irregular margin as independent predictors, and effectively stratified postoperative risk across cohorts. Clinical relevanceThis fully automated, interpretable platform enables reliable postoperative risk stratification, helping identify high-risk patients early and potentially improving outcomes after resection of solitary hepatocellular carcinoma.

Indexed as

Carcinoma, HepatocellularGadolinium DTPALarge Language ModelsLiver NeoplasmsMagnetic Resonance ImagingAgedContrast MediaFemaleHumansMaleMiddle AgedPrognosisRadiomicsRetrospective StudiesRisk AssessmentContrast MediaGadolinium DTPAgadolinium ethoxybenzyl DTPAArtificial intelligenceHepatocellular carcinomaMagnetic resonance imagingRadiomicsRisk assessment

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.